BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malla RR, Deepak K, Merchant N, Dasari VR. Breast Tumor Microenvironment: Emerging target of therapeutic phytochemicals. Phytomedicine 2020;70:153227. [PMID: 32339885 DOI: 10.1016/j.phymed.2020.153227] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Dewi C, Fristiohady A, Amalia R, Khairul Ikram NK, Ibrahim S, Muchtaridi M. Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line. Molecules 2022;27:3661. [PMID: 35744786 DOI: 10.3390/molecules27123661] [Reference Citation Analysis]
2 Varadarajan G, Thulasidas JS, Giri P, Camarillo IG, Sundararajan R. High-throughput, Label-free Proteomics Identifies Salient Proteins and Genes in MDA-MB-231 Cells Treated with Natural Neem-based Electrochemotherapy. Appl Biochem Biotechnol. [DOI: 10.1007/s12010-021-03787-3] [Reference Citation Analysis]
3 Ismail N, Shoueir KR, Toson EA. Hepatoprotective activity and free radical scavenging against induction of CCl4 in an experimental model using dendronaphthya crude extract loaded chitosan nanocarrier. Journal of Drug Delivery Science and Technology 2021;66:102906. [DOI: 10.1016/j.jddst.2021.102906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li P, Lin Z, Liu Q, Chen S, Gao X, Guo W, Gong F, Wei J, Lin H. Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway. Front Oncol 2021;11:743840. [PMID: 34722297 DOI: 10.3389/fonc.2021.743840] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Malla R, Marni R, Chakraborty A, Kamal MA. Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer. Journal of Pharmaceutical Analysis 2021. [DOI: 10.1016/j.jpha.2021.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rao Malla R, Marni R, Kumari S, Chakraborty A, Lalitha P. Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer. Clin Breast Cancer 2021:S1526-8209(21)00260-3. [PMID: 34625387 DOI: 10.1016/j.clbc.2021.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Qusa MH, Abdelwahed KS, Siddique AB, El Sayed KA. Comparative Gene Signature of (-)-Oleocanthal Formulation Treatments in Heterogeneous Triple Negative Breast Tumor Models: Oncological Therapeutic Target Insights. Nutrients 2021;13:1706. [PMID: 34069906 DOI: 10.3390/nu13051706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Malla R, Surepalli N, Farran B, Malhotra SV, Nagaraju GP. Reactive oxygen species (ROS): Critical roles in breast tumor microenvironment. Critical Reviews in Oncology/Hematology 2021;160:103285. [DOI: 10.1016/j.critrevonc.2021.103285] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
9 Pan YC, Nishikawa T, Chang CY, Tai JA, Kaneda Y. CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy. Mol Ther Oncolytics 2021;20:175-86. [PMID: 33575480 DOI: 10.1016/j.omto.2020.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Malla RR, Kiran P. Tumor microenvironment pathways: Cross regulation in breast cancer metastasis. Genes & Diseases 2020. [DOI: 10.1016/j.gendis.2020.11.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]